Less expensive drugs to exclude from obligatory small package system from July

The Korea Food and Drug Administration says low-priced and/or exit-prevention medicines should be excluded from the current small drug package system from this July.

According to the KFDA, these drugs have been big headaches for pharmaceutical manufacturers as many firms have found it difficult to deal with ever-increasing stocks of these drugs in small bundles.

Pharmaceutical companies s...